CLOSED STUDIES / Ovarian Cancer

GEICO 0103


Phase II study with Gemcitabine in prolonged infusion in patients with advanced platinum-resistant epithelial ovarian cancer.

GEICO Coordinator

Dr. Belén Ojeda

Patients Recruited

41 patients

Inclusion Closing Date

February of 2005


Prolonged Infusion Of Gemcitabine In Patients With Platinum Resistant Or Refractory Recurrent Ovarian Carcinoma: A Phase II Study Of GEICO (Spanish Group For Investigation On Ovarian Cancer). B. Ojeda, A. Gonzaléz-Martín, B. Mellado, I. Bover, X. Fabregat, M. Rubio, L. Alonso, P. Lianes, C. Churruca, A. Poveda. 2005 ASCO Annual Meeting. Abstract No: 5101.